Biggest News Aggregation in the World
📰 Managed Care News

Page 46 - Managed Care News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Managed Care. Real-time updates on events, politics, business and more.

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC - Tonix Pharmaceuticals (NASDAQ:TNXP)

Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are Indicated for the Treatment of Acute Migraine in Adults Strategic Acquisition Helps Build Tonix's Commercial
United States Peter Vozzo Ben Shannon Gregory Sullivan James Hunter Zembrace Symtouch

Centene (NYSE:CNC) Research Coverage Started at UBS Group

UBS Group assumed coverage on shares of Centene (NYSE:CNC – Get Rating) in a research report released on Tuesday, The Fly reports. The firm issued a neutral rating and a $72.00 price objective on the stock. CNC has been the subject of several other research reports. Wells Fargo & Company cut their price objective on […]
United States Lori Jean Robinson Specialty Services Jackson Hole Capital Partners Wells Fargo Company Morgan Stanley

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Centene (NYSE:CNC) PT Lowered to $83.00

Centene (NYSE:CNC – Get Rating) had its target price reduced by Truist Financial from $88.00 to $83.00 in a research report released on Tuesday morning, The Fly reports. Other research analysts have also recently issued reports about the stock. Mizuho decreased their price objective on shares of Centene from $92.00 to $80.00 and set a […]
New Zealand General New Zealand United States Lori Jean Robinson Wells Fargo Company Norges Bank

Truist Financial Trims Centene (NYSE:CNC) Target Price to $83.00

Centene (NYSE:CNC – Get Rating) had its target price cut by Truist Financial from $88.00 to $83.00 in a research report sent to investors on Tuesday morning, The Fly reports. Several other brokerages have also recently weighed in on CNC. Barclays reduced their price target on shares of Centene from $90.00 to $86.00 in a […]
United States Lori Jean Robinson Centene Corporation Jpmorgan Chase Co Centene Company Profile Morgan Stanley

Centene (NYSE:CNC) Earns Neutral Rating from Analysts at UBS Group

UBS Group assumed coverage on shares of Centene (NYSE:CNC – Get Rating) in a report released on Tuesday, The Fly reports. The firm issued a neutral rating and a $72.00 price objective on the stock. A number of other analysts also recently weighed in on CNC. StockNews.com initiated coverage on Centene in a report on […]
United States Lori Jean Robinson Warther Private Wealth Proshare Advisors Deutsche Bank Aktiengesellschaft Ep Wealth Advisors

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science